January 20, 2009 - Boston Scientific Corp. today said it was awarded a contract by the U.S. Department of Veterans Affairs (VA) for a full line of the company’s pacemakers and defibrillators.
The one-year contract took effect last month and has annual renewal options for up to four years. It includes Boston Scientific’s newest technologies in both product categories: the ALTRU family of pacemakers and the TELIGEN implantable cardioverter defibrillator.
The contract provides Boston Scientific the opportunity to supply life-saving and life-improving therapies to VA patients at risk of sudden cardiac death and bradycardia arrhythmias. Overall patient enrollment at VA Medical Centers has increased from 4.8 million in 2000 to 8 million in 2008 and is projected to continue growing.
For more information: www.bostonscientific.com
March 26, 2024 
